We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
(-8.7%)
Cap. Flow
-$6.3B
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$949M |
| 2 |
EOG Resources
EOG
|
+$470M |
| 3 |
Mastercard
MA
|
+$453M |
| 4 |
Las Vegas Sands
LVS
|
+$413M |
| 5 |
Booking.com
BKNG
|
+$413M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$712M |
| 2 |
Meta Platforms (Facebook)
META
|
+$565M |
| 3 |
PayPal
PYPL
|
+$556M |
| 4 |
Morgan Stanley
MS
|
+$541M |
| 5 |
Pfizer
PFE
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.81% |
| 2 | Financials | 12.45% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Q32 Bio
QTTB
$464M
| $664K | ﹤0.01% |
10,977
+784
| +8% | +$48.7K |
|
2902
The ONE Group
STKS
$53M
| $661K | ﹤0.01% |
61,728
+16,128
| +35% | +$190K |
|
2903
Cue Biopharma
CUE
$114M
| $659K | ﹤0.01% |
3,911
+1,134
| +41% | +$240K |
|
2904
Kinetik
KNTK
$7.98B
| $659K | ﹤0.01% |
19,932
+6,304
| +46% | +$206K |
|
2905
Ceco Environmental
CECO
$4.14B
| $654K | ﹤0.01% |
112,513
+1,483
| +1% | +$8.66K |
|
2906
EverCommerce
EVCM
$1.93B
| $654K | ﹤0.01% |
53,293
+11,137
| +26% | +$138K |
|
2907
Verastem
VSTM
$610M
| $651K | ﹤0.01% |
42,697
+634
| +2% | +$10.9K |
|
|
LITS
2908
Lite Strategy Inc
LITS
$30.9M
| $650K | ﹤0.01% |
18,049
+167
| +0.9% | +$6.56K |
|
2909
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| – | – |
0
| – | – |
|
2910
Enel Chile
ENIC
$6.28B
| $646K | ﹤0.01% |
408,572
+810
| +0.2% | +$1.45K |
|
2911
Dr. Reddy's Laboratories
RDY
$10.2B
| $644K | ﹤0.01% |
57,785
-2,161,240
| -97% | -$24.5M |
|
2912
Rimini Street
RMNI
$471M
| $638K | ﹤0.01% |
111,012
| – | – |
|
|
ENFN
2913
DELISTED
Enfusion, Inc.
ENFN
| $638K | ﹤0.01% |
50,118
+16,370
| +49% | +$250K |
|
2914
Unilever
UL
$136B
| $633K | ﹤0.01% |
12,348
-39,936
| -76% | -$2.22M |
|
2915
NI Holdings
NODK
$320M
| $629K | ﹤0.01% |
35,838
+356
| +1% | +$6.38K |
|
|
XOMA
2916
DELISTED
Xoma
XOMA
| $627K | ﹤0.01% |
21,248
+8,762
| +70% | +$200K |
|
2917
Donegal Group Class A
DGICA
$714M
| $625K | ﹤0.01% |
46,170
+266
| +0.6% | +$3.72K |
|
2918
Passage Bio
PASG
$14.1M
| $622K | ﹤0.01% |
10,072
-2,630
| -21% | -$217K |
|
2919
CytomX Therapeutics
CTMX
$754M
| $621K | ﹤0.01% |
200,943
+1,413
| +0.7% | +$5.43K |
|
2920
uniQure
QURE
$3.22B
| $620K | ﹤0.01% |
35,847
+4,967
| +16% | +$86.7K |
|
2921
Pliant Therapeutics
PLRX
$65M
| $619K | ﹤0.01% |
81,824
-7,122
| -8% | -$72.7K |
|
2922
Apyx Medical
APYX
$171M
| $616K | ﹤0.01% |
85,991
| – | – |
|
2923
Lifetime Brands
LCUT
$211M
| $615K | ﹤0.01% |
45,820
+657
| +1% | +$9.15K |
|
|
KLRS
2924
Kalaris Therapeutics
KLRS
$96.8M
| $613K | ﹤0.01% |
3,514
+26
| +0.7% | +$5.19K |
|
|
DICE
2925
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $613K | ﹤0.01% |
32,044
+10,980
| +52% | +$196K |
|
Similar funds
VFT
Nuveen's Q1 2022 Portfolio in Review
As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
- Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
- Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
- Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
- Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
- Nuveen opened 138 new positions and closed 89 in Q1 2022.
- Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.
Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.